Health & Fitness

Roughly 17 million Americans received the Johnson & Johnson Covid vaccine, only to be told later that it was the least protective of the options available in the United States. But new data suggest that the vaccine is now preventing infections, hospitalizations and deaths at least as well as the Pfizer-BioNTech and Moderna vaccines. The reasons aren’t clear, and not all experts are convinced that the vaccine has vindicated itself. But the accumulating data nonetheless offer considerable reassurance to recipients of the vaccine and, if confirmed, have broad implications for its deployment in parts of the world. In Africa, for example, distribution of a single-dose vaccine that can be refrigerated for months is by far the most practical option. Johnson & Johnson has at least tempor...

Roughly 17 million Americans received the Johnson & Johnson Covid vaccine, only to be told later that it was the least protective of the options available in the United States. But new data suggest that the vaccine is now preventing infections, hospitalizations and deaths at least as well as the Pfizer-BioNTech and Moderna vaccines. The reasons aren’t clear, and not all experts are convinced that the vaccine has vindicated itself. But the accumulating data nonetheless offer considerable reassurance to recipients of the vaccine and, if confirmed, have broad implications for its deployment in parts of the world. In Africa, for example, distribution of a single-dose vaccine that can be refrigerated for months is by far the most practical option. Johnson & Johnson has at least tempor...

Roughly 17 million Americans received the Johnson & Johnson Covid vaccine, only to be told later that it was the least protective of the options available in the United States. But new data suggest that the vaccine is now preventing infections, hospitalizations and deaths at least as well as the Pfizer-BioNTech and Moderna vaccines. The reasons aren’t clear, and not all experts are convinced that the vaccine has vindicated itself. But the accumulating data nonetheless offer considerable reassurance to recipients of the vaccine and, if confirmed, have broad implications for its deployment in parts of the world. In Africa, for example, distribution of a single-dose vaccine that can be refrigerated for months is by far the most practical option. Johnson & Johnson has at least tempor...

Roughly 17 million Americans received the Johnson & Johnson Covid vaccine, only to be told later that it was the least protective of the options available in the United States. But new data suggest that the vaccine is now preventing infections, hospitalizations and deaths at least as well as the Pfizer-BioNTech and Moderna vaccines. The reasons aren’t clear, and not all experts are convinced that the vaccine has vindicated itself. But the accumulating data nonetheless offer considerable reassurance to recipients of the vaccine and, if confirmed, have broad implications for its deployment in parts of the world. In Africa, for example, distribution of a single-dose vaccine that can be refrigerated for months is by far the most practical option. Johnson & Johnson has at least tempor...

Roughly 17 million Americans received the Johnson & Johnson Covid vaccine, only to be told later that it was the least protective of the options available in the United States. But new data suggest that the vaccine is now preventing infections, hospitalizations and deaths at least as well as the Pfizer-BioNTech and Moderna vaccines. The reasons aren’t clear, and not all experts are convinced that the vaccine has vindicated itself. But the accumulating data nonetheless offer considerable reassurance to recipients of the vaccine and, if confirmed, have broad implications for its deployment in parts of the world. In Africa, for example, distribution of a single-dose vaccine that can be refrigerated for months is by far the most practical option. Johnson & Johnson has at least tempor...

Roughly 17 million Americans received the Johnson & Johnson Covid vaccine, only to be told later that it was the least protective of the options available in the United States. But new data suggest that the vaccine is now preventing infections, hospitalizations and deaths at least as well as the Pfizer-BioNTech and Moderna vaccines. The reasons aren’t clear, and not all experts are convinced that the vaccine has vindicated itself. But the accumulating data nonetheless offer considerable reassurance to recipients of the vaccine and, if confirmed, have broad implications for its deployment in parts of the world. In Africa, for example, distribution of a single-dose vaccine that can be refrigerated for months is by far the most practical option. Johnson & Johnson has at least tempor...

Roughly 17 million Americans received the Johnson & Johnson Covid vaccine, only to be told later that it was the least protective of the options available in the United States. But new data suggest that the vaccine is now preventing infections, hospitalizations and deaths at least as well as the Pfizer-BioNTech and Moderna vaccines. The reasons aren’t clear, and not all experts are convinced that the vaccine has vindicated itself. But the accumulating data nonetheless offer considerable reassurance to recipients of the vaccine and, if confirmed, have broad implications for its deployment in parts of the world. In Africa, for example, distribution of a single-dose vaccine that can be refrigerated for months is by far the most practical option. Johnson & Johnson has at least tempor...

Roughly 17 million Americans received the Johnson & Johnson Covid vaccine, only to be told later that it was the least protective of the options available in the United States. But new data suggest that the vaccine is now preventing infections, hospitalizations and deaths at least as well as the Pfizer-BioNTech and Moderna vaccines. The reasons aren’t clear, and not all experts are convinced that the vaccine has vindicated itself. But the accumulating data nonetheless offer considerable reassurance to recipients of the vaccine and, if confirmed, have broad implications for its deployment in parts of the world. In Africa, for example, distribution of a single-dose vaccine that can be refrigerated for months is by far the most practical option. Johnson & Johnson has at least tempor...

Roughly 17 million Americans received the Johnson & Johnson Covid vaccine, only to be told later that it was the least protective of the options available in the United States. But new data suggest that the vaccine is now preventing infections, hospitalizations and deaths at least as well as the Pfizer-BioNTech and Moderna vaccines. The reasons aren’t clear, and not all experts are convinced that the vaccine has vindicated itself. But the accumulating data nonetheless offer considerable reassurance to recipients of the vaccine and, if confirmed, have broad implications for its deployment in parts of the world. In Africa, for example, distribution of a single-dose vaccine that can be refrigerated for months is by far the most practical option. Johnson & Johnson has at least tempor...

Bedridden COVID-19 patients are more at risk for anxiety and depression more than one year after their infection, according to a new study. What they found: A new study, published in The Lancet Public Health, found feelings of depression and anxiety can last about 1.5 years after experiencing severe COVID-19 symptoms. People who tested positive for COVID-19 were more likely to feel depression or trouble sleeping, per NBC News. But those issues lifted about two months later. Those who had such severe COVID-19 that they were bedridden for at least seven days were more likely to experience those mental health issues more than a year later, according to NBC News. Yes, but: COVID-19 patients who suffer from mild COVID illness are at less...